EAN 2016 Peter Goadsby Interview
Peter Goadsby discusses the rationale for using CGRP antibodies in the treatment of migraine and the study findings so far.
We’d love to hear your feedback on this activity. It helps us to continually improve our products.
Peter Goadsby discusses the rationale for using CGRP antibodies in the treatment of migraine and the study findings so far.